- All sections
- G - Physics
- G01N - Investigating or analysing materials by determining their chemical or physical properties
- G01N 33/92 - Chemical analysis of biological material, e.g. blood, urineTesting involving biospecific ligand binding methodsImmunological testing involving lipids, e.g. cholesterol
Patent holdings for IPC class G01N 33/92
Total number of patents in this class: 2036
10-year publication summary
206
|
188
|
199
|
169
|
166
|
130
|
144
|
125
|
137
|
57
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Zora Biosciences Oy | 46 |
43 |
The Regents of the University of California | 19887 |
35 |
Denka Company Limited | 2565 |
34 |
Micromass UK Limited | 1119 |
33 |
Quest Diagnostics Investments Incorporated | 406 |
23 |
Labrador Diagnostics LLC | 279 |
21 |
President and Fellows of Harvard College | 5972 |
17 |
Denka Seiken Co., Ltd. | 87 |
17 |
Board of Regents, The University of Texas System | 5782 |
15 |
Inserm (institut National de La Sante et de La Recherche Medicale) | 3367 |
15 |
Polymer Technology Systems, Inc. | 158 |
15 |
The Regents of the University of Colorado, a body corporate | 2638 |
15 |
Duke University | 3065 |
14 |
F. Hoffmann-La Roche AG | 7930 |
13 |
Laboratory Corporation of America Holdings | 822 |
13 |
Purdue Research Foundation | 3593 |
12 |
Kyowa Medex Co., Ltd. | 94 |
12 |
Roche Diagnostics Operations, Inc. | 1486 |
11 |
Wisconsin Alumni Research Foundation | 3874 |
11 |
The Brigham and Women's Hospital, Inc. | 2181 |
11 |
Other owners | 1656 |